Artificial Intelligence, BioPharma AI Biotech Exscientia Fires CEO Hopkins for Relationships With Two Employees By Frank Vinluan
BioPharma, Pharma, Artificial Intelligence Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia By Frank Vinluan
Artificial Intelligence, BioPharma AI powered and now publicly traded, Exscientia adds $464M to fuel drug R&D By Frank Vinluan
BioPharma, Artificial Intelligence AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate By Alaric DeArment
Daily, Pharma, BioPharma, Artificial Intelligence AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time By Frank Vinluan
BioPharma, Pharma, Artificial Intelligence Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap By Frank Vinluan
Artificial Intelligence, BioPharma Already Partnered With Nvidia, Iambic Adds $100M for AI Drug Discovery By Frank Vinluan
Artificial Intelligence, BioPharma Merck KGaA Expands in AI-Driven R&D With Two Drug Discovery Deals By Frank Vinluan
Artificial Intelligence, BioPharma Sanofi Inks Another AI Alliance, This Time Partnering With Insilico Medicine By Frank Vinluan
Artificial Intelligence, Devices & Diagnostics, BioPharma Getting big pharma to embrace digital, and more from INVEST PharmaTech By Frank Vinluan
BioPharma, Artificial Intelligence Biotech startup with AlphaGo-type AI approach snags $30M By Arundhati Parmar
Artificial Intelligence, BioPharma Creyon Bio gets some green for a new take on AI and genetic meds R&D By Frank Vinluan
